Catalyst Wire Dossier Catalyst Wire Dossier

Anti-CEA bispecific antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CEA bispecific antibody, covering 2012-03-19 to 2012-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer [Phase 1]

See pricing